Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07341477

Efficacy of a Dietary Supplement in Infants

Microbiome and Health-related Effects of a Dietary Supplement in Infants: a Double-blind, Randomized, Placebo-controlled Nutritional Study.

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
172 (estimated)
Sponsor
Société des Produits Nestlé (SPN) · Industry
Sex
All
Age
19 Weeks – 21 Weeks
Healthy volunteers
Accepted

Summary

This is a double-blind, randomized, placebo-controlled nutritional study of healthy term infants. The primary objective of the trial is to demonstrate a favorable change in fecal microbiome composition in infants receiving a dietary supplement compared to infants receiving a placebo supplement.

Detailed description

This is a double-blind, randomized, placebo-controlled nutritional study of healthy term infants, consisting of 2 randomized parallel arms: experimental group (EG) receiving a dietary supplement and a control group (CG) receiving a placebo supplement. The population under investigation is healthy infants aged 5 months +/- 1 week at the time of clinic visit 1. The planned sample size for this study is 172 infants (86 per study group). Each investigational product (EG and CG) will be provided in powder form and packaged in single dose stick packs. The powder will be dissolved in lukewarm formula or body temperature breastmilk and fed orally to the infants using a provided infant feeding beaker. The primary objective of the trial is to demonstrate a favorable change in fecal microbiome composition in infants receiving a dietary supplement compared to infants receiving a placebo supplement from enrolment until 5 months of intervention. In addition, fecal metabolic biomarkers, gastrointestinal (GI) related outcomes, blood markers of immune health, fecal markers of gut and immune health, bone quality, other anthropometric measurements, dietary pattern and infant illness and infection outcomes will be assessed/measured.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTExperimental GroupDietary supplement in powder form
OTHERControl Group (CG)Placebo dietary supplement in powder form

Timeline

Start date
2026-02-01
Primary completion
2026-12-01
Completion
2027-07-01
First posted
2026-01-14
Last updated
2026-01-14

Source: ClinicalTrials.gov record NCT07341477. Inclusion in this directory is not an endorsement.